Arena Pharmaceuticals

3 Biotech Stocks That Skyrocketed This Week
3 Biotech Stocks That Skyrocketed This Week
Motley Fool
biotech
Geron
imetelstat
Arena Pharmaceuticals
etrasimod
Heron Therapeutics
HTX-011
Flag link:
Arena Pharmaceuticals Takes Aim at Celgene
Arena Pharmaceuticals Takes Aim at Celgene
Motley Fool
Arena Pharmaceuticals
Celgene
etrasimod
ozanimod
ulcerative colitis
Flag link:
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Motley Fool
Arena Pharmaceuticals
etrasimod
ulcerative colitis
Flag link:
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Motley Fool
Celgene
etrasimod
ozanimod
Arena Pharmaceuticals
MS
multiple sclerois
Flag link:
Three Interviews From the J.P. Morgan Healthcare Conference
Three Interviews From the J.P. Morgan Healthcare Conference
Motley Fool
JPMHC 2018
Alnylam
Arena Pharmaceuticals
Spark Therapeutics
Flag link:
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Motley Fool
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Flag link:
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
TheStreet.com
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Flag link:
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Endpoints
Arena Pharmaceuticals
PAH
clinical trials
pulmonary arterial hypertension
ralinepag
Flag link:
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Friday
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Friday
Motley Fool
Arena Pharmaceuticals
ralinepag
Belviq
Flag link:
Arena Pharmaceuticals beats 4Q profit forecasts
Arena Pharmaceuticals beats 4Q profit forecasts
Yahoo/AP
Arena Pharmaceuticals
earnings
Flag link:
Arena Turns Page On Belviq - Restructures Deal With Eisai
Arena Turns Page On Belviq - Restructures Deal With Eisai
Seeking Alpha
Arena Pharmaceuticals
Belviq
Eisai
Flag link:
Arena Pharmaceuticals reports 3Q loss
Arena Pharmaceuticals reports 3Q loss
Yahoo/AP
earnings
Arena Pharmaceuticals
Flag link:
Drug maker faces a shareholder suit for failing to tell the whole truth
Drug maker faces a shareholder suit for failing to tell the whole truth
Stat/Pharmalot
shareholders
Arena Pharmaceuticals
Belviq
Flag link:
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Yahoo
Eisai
Arena Pharmaceuticals
Belviq XR
Flag link:
Arena Launches Drug Discovery Incubator (ARNA)
Arena Launches Drug Discovery Incubator (ARNA)
Investopedia
Arena Pharmaceuticals
R&D
drug discovery
Beacon Discovery
Flag link:
Arena to focus on R&D with new spinout and old candidates
Arena to focus on R&D with new spinout and old candidates
Fierce Biotech
Arena Pharmaceuticals
R&D
Beacon Discovery
Flag link:
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Marketwatch
Arena Pharmaceuticals
FDA
obesity
Eisai
Belviq XR
Flag link:
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Seeking Alpha
Arena Pharmaceuticals
lorcaserin
obesity
Mexico
Flag link:
Arena's Q2 Will Demonstrate The Company's Need For Cash
Arena's Q2 Will Demonstrate The Company's Need For Cash
Seeking Alpha
Arena Pharmaceuticals
Flag link:
The Little-Known Reason Arena Pharmaceuticals Could Be a Winner
The Little-Known Reason Arena Pharmaceuticals Could Be a Winner
Motley Fool
Arena Pharmaceuticals
Belviq
CNS
Boehringer Ingelheim
Flag link:

Pages